Briakinumab bests methotrexate for psoriasis
Briakinumab appears to reduce the severity of psoriasis better than methotrexate in patients with moderate or severe disease.
{{{error}}}
{{error}}
{{{ form.title }}}
*Required
{{{field.value}}}
{{{field.value}}}
{{{field.value}}}
